GLP-1 & Metabolic Intelligence Hub
The Definitive clinical resource for Glucagon-Like Peptide-1 therapies, cardiometabolic guidelines, and bedside calculations.
Metabolic Calculators
Clinical tools optimized for dosing, renal safety, and metabolic indexing.
BMI & Body Composition
Ideal and Adjusted Body Weight targets
Creatinine Clearance
Cockcroft-Gault dosing equations
MAP Calculator
Perfusion pressures and vascular targets
Calculators and content clusters on this portal are indexed against landmark trial registries (SUSTAIN-6, SELECT) and verified by the CareCalculus review board.
Peer-Reviewed Research & Insights
Trending articles, trial reviews, and clinical practice papers.
GLP-1 Medications in 2026: How They Work, Who Qualifies, and What the Evidence Actually Shows
An evidence-based guide to glucagon-like peptide-1 receptor agonists, clinical eligibility criteria, and 2026 outcomes.
Ozempic vs Wegovy: A Clinician's Side-by-Side Comparison of Dosing, Outcomes, and Patient Selection
Understanding clinical dosing, efficacy metrics, and patient selection criteria between semaglutide formulations.
GLP-1 Drugs and Cardiovascular Risk: What the SUSTAIN-6 and SELECT Trials Tell Us
An authority review of landmark clinical trials demonstrating the cardiovascular protective effects of GLP-1 therapies.
GLP-1 and Kidney Health: What the Evidence Shows
Exploring diabetic nephropathy trials and how GLP-1 medications protect glomerular filtration.
GLP-1, Hormones, and Weight: Why Metabolic Health in Women Requires a Different Approach
Analyzing the intersection of hormonal profiles, life-stage metabolic shifts, and GLP-1 receptor agonist response in female patients.
Oral GLP-1 Medications: Navigating the Transition from Injectable to Oral Therapies in H1 2026
Exploring oral semaglutide, next-generation peptide formulations, and patient compliance dynamics in clinical practice.
GLP-1 Receptor Agonists in Obesity and Cardiometabolic Disease: A Systematic Review of Efficacy, Safety, and Emerging Indications (2020–2026)
A high-impact systematic review and meta-analysis evaluating weight loss percentage, satiety markers, cardiovascular outcomes, and long-term safety profiles.
Pharmacological and Lifestyle Interventions for Healthspan Extension: A Review of Emerging Targets Including Senolytics, NAD+ Precursors, and GLP-1 Pathways
A comprehensive medical review analyzing clinical validation trials of senolytic protocols, NAD+ cofactors, and GLP-1 receptor modulation for metabolic longevity.
CME & Academic Courses
Accredited training modules for metabolic management.
Metabolic Clinical FAQ
Evidence-based answers to key clinical questions regarding GLP-1 pathways.